Literature DB >> 20550570

Epigenetic treatments of adult rats promote recovery from visual acuity deficits induced by long-term monocular deprivation.

Davide Silingardi1, Manuela Scali, Giulio Belluomini, Tommaso Pizzorusso.   

Abstract

In mammals the development of the visual system may be altered during a sensitive period by modifying the visual input to one or both eyes. These plastic processes are reduced after the end of the sensitive period. It has been proposed that reduced levels of plasticity are at the basis of the lack of recovery from early visual deprivation observed in adult animals. A developmental downregulation of experience-dependent regulation of histone acetylation has recently been found to be involved in closing the sensitive period. Therefore, we tested whether pharmacological epigenetic treatments increasing histone acetylation could be used to reverse visual acuity deficits induced by long-term monocular deprivation initiated during the sensitive period. We found that chronic intraperitoneal administration of valproic acid or sodium butyrate (two different histone deacetylases inhibitors) to long-term monocularly deprived adult rats coupled with reverse lid-suturing caused a complete recovery of visual acuity, tested electrophysiologically and behaviorally. Thus, manipulations of the epigenetic machinery can be used to promote functional recovery from early alterations of sensory input in the adult cortex.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20550570     DOI: 10.1111/j.1460-9568.2010.07261.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  41 in total

Review 1.  Epigenetic mechanisms in memory and synaptic function.

Authors:  Faraz A Sultan; Jeremy J Day
Journal:  Epigenomics       Date:  2011-04       Impact factor: 4.778

2.  Experience-dependent expression of NPAS4 regulates plasticity in adult visual cortex.

Authors:  José Fernando Maya-Vetencourt; Ettore Tiraboschi; Dario Greco; Laura Restani; Chiara Cerri; Petri Auvinen; Lamberto Maffei; Eero Castrén
Journal:  J Physiol       Date:  2012-06-06       Impact factor: 5.182

3.  Paradoxical Motor Recovery From a First Stroke After Induction of a Second Stroke: Reopening a Postischemic Sensitive Period.

Authors:  Steven R Zeiler; Robert Hubbard; Ellen M Gibson; Tony Zheng; Kwan Ng; Richard O'Brien; John W Krakauer
Journal:  Neurorehabil Neural Repair       Date:  2015-12-31       Impact factor: 3.919

4.  Natural restoration of critical period plasticity in the juvenile and adult primary auditory cortex.

Authors:  Xiaoming Zhou; Rogerio Panizzutti; Etienne de Villers-Sidani; Caroline Madeira; Michael M Merzenich
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

5.  Food restriction enhances visual cortex plasticity in adulthood.

Authors:  Maria Spolidoro; Laura Baroncelli; Elena Putignano; José Fernando Maya-Vetencourt; Alessandro Viegi; Lamberto Maffei
Journal:  Nat Commun       Date:  2011       Impact factor: 14.919

Review 6.  Interneuron epigenomes during the critical period of cortical plasticity: Implications for schizophrenia.

Authors:  Hirofumi Morishita; Marija Kundakovic; Lucy Bicks; Amanda Mitchell; Schahram Akbarian
Journal:  Neurobiol Learn Mem       Date:  2015-04-04       Impact factor: 2.877

Review 7.  Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia.

Authors:  Kim Q Do; Michel Cuenod; Takao K Hensch
Journal:  Schizophr Bull       Date:  2015-06-01       Impact factor: 9.306

Review 8.  Amblyopia: New molecular/pharmacological and environmental approaches.

Authors:  Michael P Stryker; Siegrid Löwel
Journal:  Vis Neurosci       Date:  2018-01       Impact factor: 3.241

Review 9.  Critical periods in amblyopia.

Authors:  Takao K Hensch; Elizabeth M Quinlan
Journal:  Vis Neurosci       Date:  2018-01       Impact factor: 3.241

10.  Critical period for acoustic preference in mice.

Authors:  Eun-Jin Yang; Eric W Lin; Takao K Hensch
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.